SCHEMBL7683114

SCHEMBL7683114

COc1nc2cc(Cl)c(Cl)c(-c3c(-c4ccccc4)nnn3C)c2nc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
NR1I3 Q14994 2/20 0.37
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
BRCA1 P38398 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAT2A P31153 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681595 0.91 NR1I3 (0.37) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL27413977 0.87 SMN1; SMN2 (0.39) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL7672900 0.81 RORC (0.31) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL7680558 0.81 SMN1; SMN2 (0.37) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL27555336 0.80 NPC1 (0.36) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL7673858 0.76 RORC (0.31) NR1I3RORC
SCHEMBL7675073 0.75 NPC1 (0.36) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL7681496 0.74 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2HRH4
SCHEMBL7678666 0.72 RORC (0.33) SMN1; SMN2NPC1NFKB1RAB9ANFKB2
SCHEMBL7682758 0.71 CYP11B2 (0.46) SMN1; SMN2NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed